Theralase Technologies Inc. (TSXV:TLT)
0.1900
0.00 (0.00%)
Oct 1, 2025, 9:32 AM EDT
Theralase Technologies Revenue
Theralase Technologies had revenue of 219.74K CAD in the quarter ending June 30, 2025, with 117.90% growth. This brings the company's revenue in the last twelve months to 1.07M, up 16.00% year-over-year. In the year 2024, Theralase Technologies had annual revenue of 1.03M, down -3.45%.
Revenue (ttm)
1.07M
Revenue Growth
+16.00%
P/S Ratio
45.73
Revenue / Employee
53.40K
Employees
20
Market Cap
48.84M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.03M | -36.88K | -3.45% |
Dec 31, 2023 | 1.07M | -68.26K | -6.00% |
Dec 31, 2022 | 1.14M | 357.93K | 45.85% |
Dec 31, 2021 | 780.64K | -148.48K | -15.98% |
Dec 31, 2020 | 929.12K | -34.93K | -3.62% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
dentalcorp Holdings | 1.62B |
Trulieve Cannabis | 1.62B |
Sienna Senior Living | 929.68M |
Cronos Group | 177.69M |
WELL Health Technologies | 1.12B |
Extendicare | 1.51B |
Theralase Technologies News
- 7 days ago - Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus - Newsfile Corp
- 27 days ago - Q2 2025 Theralase Technologies Inc Earnings Call Transcript - GuruFocus
- 4 weeks ago - Theralase(R) Extends Warrants - Newsfile Corp
- 5 weeks ago - Theralase(R) Releases 2Q2025 Financial Statements - Newsfile Corp
- 2 months ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp
- 3 months ago - Theralase(R) Extends Warrants - Newsfile Corp
- 3 months ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp
- 3 months ago - Theralase Completes Annual General and Special Meeting - Newsfile Corp